J&J files for authorization of COVID-19 vaccine booster Johnson & Johnson said on Tuesday it had submitted data to the U.S. Food and Drug Administration for emergency use authorization of a booster shot of its COVID-19 vaccine in people aged 18 and older. Johnson & Johnson seeks FDA emergency authorization for COVID-19 booster shotThe company saw a "substantial increase" in immune response when a booster of its vaccine was given six months after the first shot. J&J asks for emergency use authorization of COVID-19 vaccine boosterJohnson & Johnson announced Tuesday that it has asked the Food and Drug Administration (FDA) to grant emergency authorization for a booster shot of its COVID-19 vaccine for individuals aged 18 years and older. Biden administration expects J&J boosters in the next few weeksFDA has scheduled an advisory meeting over the booster ahead of receiving an application. J&J asks FDA to approve COVID-19 booster shotsThe company released data last month showing a booster strengthened the protection offered by its vaccine. Johnson & Johnson submits vaccine booster data to FDA; Washington National Cathedral to mark 700K lives lost: COVID updatesThe U.S. is on the verge of reporting as many COVID-19 this year as in all of 2020, according to Johns Hopkins University data. Latest updates.